Uthever NMN
Commercial- Indications
- Aging
Company intelligence / Profile preview
EffePharm
Chinaeffepharm.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
EffePharm provides science-backed bioactive ingredients with clinical validation. Their flagship product Uthever® NMN has published human clinical trial data supporting its use in longevity applications. The company supplies over 2000 business partners worldwide and licenses its “Uth” series trademarks to more than forty consumer brands.
- Therapeutic areas
- OtherDermatologyMetabolic Disorders
- Modalities
- Bioactive ingredients (notably NMN and NMNH)Liposomal formulations (LipoAvail liposomal delivery system)Advanced ingredient delivery systems (EffePLUS platform)Biosynthesis technology for raw material production
- Industry
- Food & Nutrition
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Over two thousand global business partners“Uth” series trademarks licensed to over forty consumer brands.
Beyond the preview
Go deeper on EffePharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EffePharm.